查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842092

美國腫瘤資訊系統市場規模、佔有率和趨勢分析報告：按產品和服務、應用、最終用途和細分市場預測，2025 年至 2033 年

U.S. Oncology Information Systems Market Size, Share & Trends Analysis Report By Product & Service, By Application, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

預計 2024 年美國腫瘤資訊系統市值將達到 9.029 億美元，2025 年至 2033 年的複合年成長率將達到 7.56%。

美國市場的發展受到各年齡層癌症發生率上升以及對先進創新型腫瘤資訊系統 (OIS) 需求成長的推動。由於癌症發病率上升和醫療保健預算增加，美國醫院和癌症研究所擴大採用癌症資訊解決方案。

由於癌症發病率上升以及先進醫療IT解決方案的日益整合，美國腫瘤資訊系統 (OIS) 市場預計將經歷顯著成長。根據美國國家癌症美國的數據，到2024年，美國將新增超過200萬例癌症病例，並有611,720例癌症相關死亡病例。不斷上升的發病率需要強大的數據管理和臨床決策支援系統，從而加速了醫療機構對OIS平台的需求。

此外，美國醫療保健產業正在經歷數位科技應用的激增，旨在最佳化工作流程、行政職能和患者照護。具有治療計劃、數據視覺化和患者追蹤等先進功能的腫瘤資訊系統正在成為改善臨床結果和營運效率的關鍵工具。

此外，在公共和私人機構的支持下，腫瘤學研發投入的增加正在刺激產品創新。例如，成立於1978年的著名非營利組織美國近距離放射治療協會（ABS）積極透過專業教育、研究推廣和提高意識的舉措，支持近距離放射治療的發展。此類組織在推動癌症治療創新和知識傳播方面發揮著至關重要的作用。

人工智慧 (AI) 日益融入腫瘤學工作流程，預計將進一步推動美國腫瘤資訊系統產業的擴張。 2024 年 10 月，McKesson Corporation 的子公司 Ontada 與微軟合作，利用 Azure AI（包括 Azure OpenAI 服務）增強非結構化腫瘤資料的處理能力。此次合作旨在從複雜的臨床文件中提取切實可行的見解，最終支持數據驅動的治療計劃和即時決策。

癌症發病率上升、醫療 IT 應用日益普及、研發活動活性化以及人工智慧主導的創新都是預計在預測期內共同推動美國癌症資訊系統市場持續成長的因素。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國腫瘤資訊系統市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場前景。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國腫瘤資訊系統市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國腫瘤資訊系統市場：產品與服務估計與趨勢分析

  • 細分儀表板
  • 美國腫瘤資訊系統市場產品與服務變化分析
  • 2021-2033 年美國腫瘤資訊系統市場規模及趨勢分析（依產品及服務）
  • 軟體
    • 病人資訊系統
    • 治療計劃系統
  • 專業服務

第5章美國腫瘤資訊系統市場：應用估計與趨勢分析

  • 細分儀表板
  • 美國腫瘤資訊系統市場使用變化分析
  • 2021-2033 年美國腫瘤資訊系統市場規模及應用趨勢分析
  • 腫瘤內科
  • 放射腫瘤學
  • 外科腫瘤學

第6章美國腫瘤資訊系統市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 美國腫瘤資訊系統市場最終用途差異分析
  • 美國腫瘤資訊系統市場規模和趨勢分析（按最終用途），2021-2033 年
  • 醫院和診斷影像
  • 消融護理中心和癌症護理中心
  • 政府機構
  • 研究設施

第7章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Elekta AB
    • Accuray Incorporated
    • Varian Medical Systems（Siemens Healthineers）
    • RaySearch Laboratories
    • Oracle Corporation
    • BrainLab
    • Philips Healthcare
    • Prowess, Inc.
    • DOSIsoft SA
    • ViewRay Inc.
    • MIM Software
    • Flatiron
Product Code: GVR-4-68040-287-5

Market Size & Trends:

The U.S. oncology information systems market size was estimated at USD 900.29 million in 2024 and is projected to grow at a CAGR of 7.56% from 2025 to 2033. The growing prevalence of cancer among various demographics and the rising demand for advanced innovative oncology information systems (OIS) are some of the driving factors for the U.S. market. Oncology information solutions deployment is high in hospitals & cancer research institutes in the U.S. due to the rise in the prevalence of cancer and the increase in healthcare expenditure budget.

The U.S. oncology information system (OIS) market is poised for significant growth, driven by the rising cancer burden and the increasing integration of advanced healthcare IT solutions. According to the National Cancer Institute, over 2 million new cancer cases are projected to be diagnosed in the U.S. in 2024, with an estimated 611,720 cancer-related deaths. This escalating disease incidence necessitates robust data management and clinical decision support systems, thereby accelerating the demand for OIS platforms across healthcare facilities.

Moreover, the healthcare sector in the U.S. has witnessed a surge in the adoption of digital technologies aimed at optimizing workflows, administrative functions, and patient care delivery. Oncology information systems, equipped with advanced functionalities such as treatment planning, data visualization, and patient tracking, have emerged as critical tools for improving clinical outcomes and operational efficiency.

Furthermore, increased investment in oncology R&D, supported by both public and private organizations, is fostering product innovation. For instance, the American Brachytherapy Society (ABS), a prominent nonprofit founded in 1978, actively supports the advancement of brachytherapy through professional education, research promotion, and awareness-building initiatives. Such organizations play a pivotal role in driving innovation and knowledge dissemination in oncology care.

The growing integration of artificial intelligence (AI) into oncology workflows is expected to further propel the expansion of the U.S. oncology information systems industry. In October 2024, Ontada, a McKesson Corporation subsidiary, partnered with Microsoft to utilize Azure AI, including Azure OpenAI Service, to enhance the processing of unstructured oncology data. This collaboration aims to extract actionable insights from complex clinical documents, ultimately supporting data-driven treatment planning and real-time decision-making.

These factors, such as rising cancer prevalence, expanding healthcare IT adoption, increased R&D activities, and AI-driven innovation, are collectively expected to drive sustained growth of the U.S. oncology information system market over the forecast period.

U.S. Oncology Information Systems Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. oncology information systems market report based on product & service, application, and end use:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
    • Patient Information Systems
    • Treatment Planning Systems
  • Professional Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Medical Oncology
  • Radiation Oncology
  • Surgical Oncology
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Diagnostic Imaging Centers
  • Ablation Care Centers and Cancer Care Centers
  • Government Institutions
  • Research Facilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Oncology Information Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. U.S. Oncology Information Systems Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. U.S. Oncology Information Systems Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Oncology Information Systems Market Product & Service Movement Analysis
  • 4.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Patient Information Systems
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Treatment Planning Systems
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Professional Services
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Oncology Information Systems Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Oncology Information Systems Market Application Movement Analysis
  • 5.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Medical Oncology
    • 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Radiation Oncology
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Surgical Oncology
    • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Oncology Information Systems Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Oncology Information Systems Market End Use Movement Analysis
  • 6.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospitals & Diagnostic Imaging
    • 6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Ablation Care Centers and Cancer Care Centers
    • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Government Institutions
    • 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Research Facilities
    • 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Elekta AB
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Accuray Incorporated
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Varian Medical Systems (Siemens Healthineers)
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. RaySearch Laboratories
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Oracle Corporation
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. BrainLab
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Philips Healthcare
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Prowess, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. DOSIsoft S.A.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. ViewRay Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. MIM Software
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Flatiron
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. oncology information systems market, by component, 2021 - 2033 (USD Million)
  • Table 3 U.S. oncology information systems market, by application, 2021 - 2033 (USD Million)
  • Table 4 U.S. oncology information systems market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. oncology information systems market: Market outlook
  • Fig. 5 U.S. oncology information systems market: Segment outlook
  • Fig. 6 U.S. oncology information systems market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. oncology information systems market driver impact
  • Fig. 9 U.S. oncology information systems market restraint impact
  • Fig. 10 U.S. oncology information systems market: Product & Service outlook and key takeaways
  • Fig. 11 U.S. oncology information systems market: Product & Service movement analysis
  • Fig. 12 Software market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 13 Patient information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Treatment planning systems market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 15 Professional services market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 16 U.S. oncology information systems market: Application outlook and key takeaways
  • Fig. 17 U.S. oncology information systems market: Application movement analysis
  • Fig. 18 Medical oncology market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 19 Medical oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Surgical oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. oncology information systems market: End use outlook and key takeaways
  • Fig. 22 U.S. oncology information systems market: End use movement analysis
  • Fig. 23 Hospitals & diagnostic imaging centers market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 24 Ablation care centers and cancer care centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Government institutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Research facilities market estimates and forecasts, 2021 - 2033 (USD Million)